Advertisement

Topics

Angion Biomedica Exclusively In-licenses Aldosterone Synthase Inhibitors from ElexoPharm GmbH Complementing its Ongoing Program in Chronic Kidney Disease

07:00 EDT 22 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Angion Biomedica Corp. announced today that it has signed an exclusive license with ElexoPharm GmbH of Saarbrücken, Germany, for compounds that target aldosterone synthase (CYP11B2), a cytochrome P450 enzyme involved in the gen...

Other Sources for this Article

Media:
Angion Biomedica Corp.
Joanne Bazilio-Johnson, (516) 326-1200 ext. 200
jjohnson@angion.com

NEXT ARTICLE

More From BioPortfolio on "Angion Biomedica Exclusively In-licenses Aldosterone Synthase Inhibitors from ElexoPharm GmbH Complementing its Ongoing Program in Chronic Kidney Disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Enzymes
Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into different molecules, called products. Almost all chemical re...

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...